24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BeyondBio SCALE
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:53
Binance is back online after a record crypto theft. The questions are far from settled
20:53
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
20:25
"Security teams are struggling to handle this AI threat"
20:24
"To build a company in Israel for the last four years is not an easy mission"
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli startup Coldi is deploying AI agents to take over the cold call
2
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
3
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
4
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
5
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
More news
BeyondBio SCALE
2 stories about BeyondBio SCALE
Six Israeli startups selected to participate in BeyondBio SCALE program
18.12.22
|
CTech
Improving cancer treatment, enabling efficient ways for sharing of data for advanced research, and AI for predicting drug safety, are all among the innovative solutions developed by the six startups selected for BeyondBio SCALE - a joint innovation program of AstraZeneca, Accenture, Clalit and AWS
AstraZeneca, Accenture, AWS and Clalit Health Services launch BeyondBio SCALE startup program
02.08.22
|
James Spiro
The program is expected to start in November and run until next summer, and will assist startups to expand into markets with the help of program collaborators and their clinical, commercial, and technical expertise